Peripheral Nerve Stimulation Registry for Intractable Migraine Headache
NCT ID: NCT02227758
Last Updated: 2019-02-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2012-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
NCT00200109
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
NCT00257985
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839
A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic Migraine
NCT01653340
Evaluation of a New Treatment for Migraine Attacks
NCT01880671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
implanted chronic migraine patients
Patients diagnosed with chronic migraine, failed 3 or more preventative drugs, with at least moderate disability, and implanted with a St. Jude Medical Conformité Européenne approved implantable neurostimulation system
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heilig Hartziekenhuis
Roeselare, West-Vlaanderen, Belgium
Centre Hospitalier Régional de la CITADELLE
Liège, , Belgium
Klinikum Delmenhorst GmbH
Delmenhorst, Großherzogtum Oldenburg, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Praxis fur Neurologie, Spezielle Schmerztherapie, Psychotherapie
Essen, North Rhine-Westphalia, Germany
Universitätsklinikum Essen
Essen, North Rhine-Westphalia, Germany
Migräne and Kopfschmerzklinik Königstein
Königstein, Saxony, Germany
Schmerzklinik und Praxis an der Schmerzklinik Kiel
Kiel, Schleswig-Holstein, Germany
Neurologische Klinik und Poliklinik Charité Campus Mitte
Berlin, , Germany
Centre Hospitalier de Luxembourg
Luxembourg, , Luxembourg
Hospital Universitario Virgen del Rocio
Seville, Andalusia, Spain
Hospital Universitario
Madrid, , Spain
Hospital Puerta de Hierro
Madrid, , Spain
Karolinska Hospital
Stockholm, Stockholm County, Sweden
John Radcliffe hospital
Oxford, Oxfordshire, United Kingdom
Royal London Hospital
London, Royal London Hospital, United Kingdom
Seacroft Hospital
Leeds, Yorkshire, United Kingdom
King's College Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NM-11-059-EU-ON
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.